Nuron Biotech Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nuron biotech inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nuron Biotech Inc Today - Breaking & Trending Today

Worldwide Pneumococcal Vaccine Industry to 2025 - Development of Protein-Based Combination Pneumococcal Vaccines Presents Opportunities


Segments Covered
By Vaccine, Conjugate Vaccines are anticipated to account as the fastest-growing segment during the forecasted period. They are considered to be more robust over polysaccharide ones and hence are more preferred leading to high demand. It also covers a wide age group as it can vaccinate an infant from 6 weeks old to 5years of age and for people over 50 + age groups, reducing asymptomatic delivery of the bacteria, and thus resulting in marked group immunity.
By Product Type, Prevnar-13 is estimated to account for the fastest-growing segment during the forecasted period as it is recommended by the WHO as an efficient vaccine against pneumonia and has therefore been the widely adopted 13-valent PCV vaccines across the world. It has also been used as an essential vaccine for people above 50 age groups. ....

United States , United Kingdom , Sanofi Pasteur , Laura Wood , Glaxosmithkline Plc , Emergent Biosolutions Inc , Merck Co , Distributor Partner Companies , Merck Co Inc , Astellas Pharma Inc , Lg Chem Ltd , Pfizer Inc , Development Of Protein , Porter Five Forces Analysis , Custom Research , Nuron Biotech Inc , Office Hours Call , Research Methodology , Walvax Biotechnology Co Ltd , Company Profiles , E St Office Hours Call , China National Biotec Group , Panacea Biotec , Minhai Biotechnology Corporation , Serum Institute Of India Pvt , Pnuvax Incorporated ,